2021
DOI: 10.7759/cureus.15291
|View full text |Cite
|
Sign up to set email alerts
|

Sclerosing Encapsulating Peritonitis: A Rare Cause of Intestinal Obstruction

Abstract: Sclerosing encapsulating peritonitis (SEP) is a rare clinical entity that may cause small bowel obstruction. It is characterized by a thick fibrocollagenous cocoon-like membrane. Surgical intervention is the mainstay of treatment. A 36-year-old Pakistani man presented with recurrent attacks of colicky abdominal pain, distention, vomiting, and constipation. Abdominal CT revealed a thick enhanced membrane forming a sac that contained clusters of small intestinal loops. Exploratory laparotomy showed a thick membr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…The formation of a fibrous cocoon and subsequent encapsulation of the bowel follows a second hit, such as cessation of PD or kidney transplantation. 4 Primary SEP, as seen in this case, does not appear to have any definitive causes.…”
mentioning
confidence: 47%
“…The formation of a fibrous cocoon and subsequent encapsulation of the bowel follows a second hit, such as cessation of PD or kidney transplantation. 4 Primary SEP, as seen in this case, does not appear to have any definitive causes.…”
mentioning
confidence: 47%
“…We report two cases of abdominal cocoon occurring as a sequela in recovered severe COVID-19, diagnosed in middle-aged individuals with no comorbidities or any known cause of abdominal cocoon and negative RT-PCR on admission. There have been reports of abdominal cocoon formation during the active stage of COVID-19 [ 5 , 6 ], but none as a sequela of COVID-19, and this is the first case report to the best of our knowledge. In a report by Mofti et al [ 5 ], the patient recovered from severe COVID-19, was about to be discharged when he experienced abdominal discomfort associated with nausea and decreased bowel movements, whereas in our case the patient presented with symptoms six months after recovery from severe COVID-19.…”
Section: Discussionmentioning
confidence: 90%
“…In the present case, surgical management was pursued due to both intestinal obstruction and elevated levels of inflammatory markers. Laparoscopy has both diagnostic and therapeutic purposes; technically, it is a real therapeutic challenge in patients with an advanced abdominal cocoon [ 12 ].…”
Section: Discussionmentioning
confidence: 99%